Literature DB >> 9445044

Entry of amphotropic and 10A1 pseudotyped murine retroviruses is restricted in hematopoietic stem cell lines.

D von Laer1, S Thomsen, B Vogt, M Donath, J Kruppa, A Rein, W Ostertag, C Stocking.   

Abstract

Although transduction with amphotropic murine leukemia virus (MLV) vectors has been optimized successfully for hematopoietic differentiated progenitors, gene transfer to early hematopoietic cells (stem cells) is still highly restricted. A similar restriction to gene transfer was observed in the mouse stem cell line FDC-Pmix compared with transfer in the more mature myeloid precursor cell line FDC-P1 and the human erythroleukemia cell line K562. Gene transfer was not improved when the vector was pseudotyped with gp70SU of the 10A1 strain of MLV, which uses the receptor of the gibbon ape leukemia virus (Pit1), in addition to the amphotropic receptor (Pit2). Although 10A1 and amphotropic gp70SU bound to FDC-P1, K562, and fibroblasts, no binding to FDC-Pmix cells was detected. This indicates that FDC-Pmix cells lack functional Pit2 and Pit1 receptors. Pseudotyping with the vesicular stomatitis virus G protein improved transduction efficiency in FDC-Pmix stem cells by 2 orders of magnitude, to fibroblast levels, confirming a block to retroviral infection at the receptor level.

Entities:  

Mesh:

Year:  1998        PMID: 9445044      PMCID: PMC124622     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Expression of the GM-CSF gene after retroviral transfer in hematopoietic stem cell lines induces synchronous granulocyte-macrophage differentiation.

Authors:  U Just; C Stocking; E Spooncer; T M Dexter; W Ostertag
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

2.  Construction and use of a safe and efficient amphotropic packaging cell line.

Authors:  D Markowitz; S Goff; A Bank
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

3.  Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy.

Authors:  C Münk; J Löhler; V Prassolov; U Just; M Stockschläder; C Stocking
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

4.  Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses.

Authors:  D Ott; R Friedrich; A Rein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.

Authors:  L H Evans; R P Morrison; F G Malik; J Portis; W J Britt
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

6.  Effect of src infection on long-term marrow cultures: increased self-renewal of hemopoietic progenitor cells without leukemia.

Authors:  D Boettiger; S Anderson; T M Dexter
Journal:  Cell       Date:  1984-03       Impact factor: 41.582

7.  Nucleotide sequence of a cDNA clone encoding the entire glycoprotein from the New Jersey serotype of vesicular stomatitis virus.

Authors:  C J Gallione; J K Rose
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

8.  Retroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells.

Authors:  G Beck-Engeser; C Stocking; U Just; L Albritton; M Dexter; E Spooncer; W Ostertag
Journal:  Hum Gene Ther       Date:  1991       Impact factor: 5.695

9.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

10.  Growth of factor-dependent hemopoietic precursor cell lines.

Authors:  T M Dexter; J Garland; D Scott; E Scolnick; D Metcalf
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  8 in total

1.  Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus.

Authors:  H Miletic; M Bruns; K Tsiakas; B Vogt; R Rezai; C Baum; K Kühlke; F L Cosset; W Ostertag; H Lother; D von Laer
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes.

Authors:  Michael D Mühlebach; Isabel Schmitt; Stefanie Steidl; Jörn Stitz; Matthias Schweizer; Thomas Blankenstein; Klaus Cichutek; Wolfgang Uckert
Journal:  J Mol Med (Berl)       Date:  2003-10-24       Impact factor: 4.599

3.  A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes.

Authors:  D Lavillette; M Maurice; C Roche; S J Russell; M Sitbon; F L Cosset
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

4.  Mus cervicolor murine leukemia virus isolate M813 belongs to a unique receptor interference group.

Authors:  V Prassolov; S Hein; M Ziegler; D Ivanov; C Münk; J Löhler; C Stocking
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocalization of gp70 and target cells on fibronectin CH-296.

Authors:  E C MacNeill; H Hanenberg; K E Pollok; J C van der Loo; M F Bierhuizen; G Wagemaker; D A Williams
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Sodium-dependent myo-inositol transporter 1 is a cellular receptor for Mus cervicolor M813 murine leukemia virus.

Authors:  Sibyll Hein; Vladimir Prassolov; Yuanming Zhang; Dmitry Ivanov; Jürgen Löhler; Susan R Ross; Carol Stocking
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 7.  The Impact of the Cellular Origin in Acute Myeloid Leukemia: Learning From Mouse Models.

Authors:  James Neil Fisher; Natarajaswamy Kalleda; Vaia Stavropoulou; Juerg Schwaller
Journal:  Hemasphere       Date:  2019-01-30

8.  Characterizing the anti-HIV activity of papuamide A.

Authors:  Cynthia D Andjelic; Vicente Planelles; Louis R Barrows
Journal:  Mar Drugs       Date:  2008-10-08       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.